EFFECT OF GOVERNMENT AND COMMERCIAL WARNINGS ON REDUCING PRESCRIPTION MISUSE - THE CASE OF PROPOXYPHENE

被引：66

作者：

SOUMERAI, SB ^{[1
]}

AVORN, J ^{[1
]}

GORTMAKER, S ^{[1
]}

HAWLEY, S ^{[1
]}

机构：

[1] HARVARD UNIV,SCH PUBL HLTH,DEPT BEHAV SCI,BOSTON,MA 02115

来源：

关键词：

D O I：

10.2105/AJPH.77.12.1518

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：1518 / 1523

页数：6

共 59 条

[1]

*AM MED ASS, 1980, AMA DRUG EV, P214

[2]

[Anonymous], 1975, PHARM TIMES, V41, P39

[3]

[Anonymous], 1979, PHARM TIMES, V45, P29

[4]

[Anonymous], 1984, PHARM TIMES, V50, P27

[5]

[Anonymous], 1976, PHARM TIMES, V42, P37

[6]

[Anonymous], 1974, PHARM TIMES, V40, P35

[7]

*APPL MAN SCI, 1974, 2 DRUG B SURV

AVORN, J ;

SOUMERAI, SB .

AVORN, J ;

CHEN, M ;

HARTLEY, R .

[10]

BAUM C, 1987, PUBLIC HEALTH REP, V102, P426